http://www.zibb.com/healthcare/theme/cq/Abbott+Laboratories Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Tue, 17 Nov 2009 06:00:00 GMTTue, 17 Nov 2009 06:00:00 GMT608831http://www.zibb.com/healthcare/theme/cq/Abbott+Laboratories http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0796.htm?referrer=RSSAbbott to Develop New Heart Failure Test on ARCHITECT® Immunochemistry Diagnostics Platformhttp://www.abbott.com/global/url/pressRelease/en_US/60.5:5/Press_Release_0796.htm?referrer=RSSAbbott LaboratoriesTue, 17 Nov 2009 06:00:00 GMThttp://www.foxbusiness.com/story/markets/industries/health-care/abbott-laboratories-reports-positive-results-niaspan/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+foxbusiness%2Fhealthcare+%28FOXBusiness.com+-+Industries+-+Health+Care%29Abbott Laboratories (ABT) announced on Monday positive results of cholesterol drug Niaspan.http://www.foxbusiness.com/story/markets/industries/health-care/abbott-laboratories-reports-positive-results-niaspan/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+foxbusiness%2Fhealthcare+%28FOXBusiness.com+-+Industries+-+Health+Care%29Abbott LaboratoriesMon, 16 Nov 2009 22:36:38 GMThttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3457176&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3457176&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2265021765%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directoryhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3457176&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=biotechnology%20pharmaceutical&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R%3adate&R=3457176&THISHREF=http%3a//c.moreover.com/click/here.pl%3fz2265021765%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAbbott LaboratoriesThu, 15 Oct 2009 14:38:16 GMThttp://seekingalpha.com/article/166281-earnings-preview-abbott-labs?source=feedAbbott Labs (ABT) is expected to report Q3 earnings Wednesday, October 14 before market open, with a conference call scheduled for 9 am ET.http://seekingalpha.com/article/166281-earnings-preview-abbott-labs?source=feedAbbott LaboratoriesTue, 13 Oct 2009 18:10:40 GMThttp://finance.yahoo.com/news/Earnings-Preview-Abbott-apf-988328403.html?x=0&.v=3WASHINGTON (AP) -- Drug and medical-device company Abbott Laboratories is scheduled to report earnings for the third quarter on Wednesday. The following is a summary ofhttp://finance.yahoo.com/news/Earnings-Preview-Abbott-apf-988328403.html?x=0&.v=3Abbott LaboratoriesMon, 12 Oct 2009 15:48:03 GMThttp://www.ft.com/cms/s/40f75a32-ac09-11de-950b-00144feabdc0,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F3%2F40f75a32-ac09-11de-950b-00144feabdc0.html%3Fftcamp%3Drss%26nclick_check%3D1&_i_referer=&ftcamp=rss&nclick_check=1Its best-selling drug, the TriCor cholesterol treatment, sold in partnership with Abbott, faces a threat from generic competition as of 2011. Operating margins of about 18 per cent are also below the 25 per cent typical of a speciality pharma company.http://www.ft.com/cms/s/40f75a32-ac09-11de-950b-00144feabdc0,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F3%2F40f75a32-ac09-11de-950b-00144feabdc0.html%3Fftcamp%3Drss%26nclick_check%3D1&_i_referer=&ftcamp=rss&nclick_check=1Abbott LaboratoriesMon, 28 Sep 2009 21:39:55 GMThttp://www.marketwatch.com/story/abbott-labs-to-acquire-rest-of-evalve-inc-2009-09-10?siteid=yhoof2SAN FRANCISCO (MarketWatch) -- Abbott Laboratories said late Thursday it will acquire the 90% of medical device maker Evalve Inc. it does not already own for $320 million cash. Evalve makes devices used to repair heart valves in a minimally invasive manner. Abbott said it will also pay anhttp://www.marketwatch.com/story/abbott-labs-to-acquire-rest-of-evalve-inc-2009-09-10?siteid=yhoof2Abbott LaboratoriesThu, 10 Sep 2009 20:54:39 GMThttp://www.industrialinfo.com/showAbstract.jsp?newsitemID=148593Net earnings for the company were down 2.6% from 2Q08, moving from $1.32 billion last year to $1.29 billion this year.http://www.industrialinfo.com/showAbstract.jsp?newsitemID=148593Abbott LaboratoriesFri, 17 Jul 2009 00:00:00 GMThttp://www.fda.gov/cder/ogd/AG_Listing.htmNote: This list of authorized generic drugs (AGs) was created from a manual review of FDA’s database of annual reports submitted to the FDA since January 1, 1999 by sponsors of new drug applications (NDAs).http://www.fda.gov/cder/ogd/AG_Listing.htmAbbott LaboratoriesFri, 27 Mar 2009 11:40:00 GMThttp://biz.yahoo.com/ap/081126/abbott_lobbying.html?.v=1Abbott spent $1.8M lobbying government in 3Q. - WASHINGTON (AP) -- Drug and medical device maker Abbott Laboratories spent nearly $1.8 million lobbying the federal government on health care issues in the third quarter, according to a recent disclosure form.http://biz.yahoo.com/ap/081126/abbott_lobbying.html?.v=1Abbott LaboratoriesWed, 26 Nov 2008 16:03:30 GMThttp://community.investopedia.com/news/IA/2008/Wyeths-Day-In-Court-WYE1106.aspx?partner=YahooSAPharmaceutical makers are anxiously awaiting the results of Wyeth's (NYSE:WYE) product liability case being debated by the U.S. Supreme Court. The question surrounds how broad a spectrum of possible injuries should the company be responsible for if someone suffers harm.http://community.investopedia.com/news/IA/2008/Wyeths-Day-In-Court-WYE1106.aspx?partner=YahooSAAbbott LaboratoriesThu, 06 Nov 2008 17:20:06 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/081031/eu_france_earns_sanofi_aventis.html?.v=9Sanofi best-sellers help lift net profit in 3Q. - PARIS (AP) -- French pharmaceutical giant Sanofi-Aventis said Friday that higher sales of blood thinners Lovenox and Plavix and diabetes treament Lantus helped lift net profit by 1.9 percent in the third quarter.http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/081031/eu_france_earns_sanofi_aventis.html?.v=9Abbott LaboratoriesFri, 31 Oct 2008 11:01:41 GMThttp://www.cnbc.com/id/27166899/site/14081545?__source=yahoo|headline|quote|text|&par=yahooJohnson & Johnson has weathered the market sell off better than most, but will the quarterly results give investors enough reasons to keep on buying? Keep an eye on two things: Remicade and stents.http://www.cnbc.com/id/27166899/site/14081545?__source=yahoo|headline|quote|text|&par=yahooAbbott LaboratoriesMon, 13 Oct 2008 20:24:49 GMThttp://www.news-medical.net/?id=41162Biovail Corporation today announced that the United States Food and Drug Administration (FDA) has accepted the Company's abbreviated new drug application (ANDA) for a generic formulation of 145mg and 48mg strengths of fenofibrate tablets (sold under the brand name Tricor by Abbott Laboratories).http://www.news-medical.net/?id=41162Abbott LaboratoriesThu, 04 Sep 2008 00:50:00 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=4402News and press releases from the pharmaceutical industry. Comprehensive news coverage for the pharmaceutical sector from PharmiWeb.comhttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=4402Abbott LaboratoriesWed, 27 Aug 2008 00:00:00 GMThttp://www.fool.com/investing/dividends-income/2008/07/18/foolish-forecast-how-quickly-can-merck-turn-it-aro.aspx(NYSE: MRK) has had a string of tough breaks this year. We'll get a closer look at whether its turnaround is imminent when it releases earnings on the other side of the weekend, but until then, here's a preview of what to expect. What analysts say:http://www.fool.com/investing/dividends-income/2008/07/18/foolish-forecast-how-quickly-can-merck-turn-it-aro.aspxAbbott LaboratoriesFri, 18 Jul 2008 20:40:53 GMThttp://www.forbes.com/healthcare/2008/05/28/medtronic-boston-scientific-markets-equity-cx_lal_0528markets39.html?feed=rss_business_healthcareA patent infringment suit was settled between the two medical device makers.http://www.forbes.com/healthcare/2008/05/28/medtronic-boston-scientific-markets-equity-cx_lal_0528markets39.html?feed=rss_business_healthcareAbbott LaboratoriesWed, 28 May 2008 21:35:10 GMThttp://www10.nytimes.com/2008/04/29/business/29merck.html?_r=5&partner=rssnyt&emc=rssAn experimental cholesterol drug being developed by Merck & Company was rejected by the Food and Drug Administration, the company said on Monday.http://www10.nytimes.com/2008/04/29/business/29merck.html?_r=5&partner=rssnyt&emc=rssAbbott LaboratoriesTue, 29 Apr 2008 04:52:47 GMThttp://online.barrons.com/article/SB120907254611342857.html?mod=yahoobarrons&ru=yahooAMID THE MAELSTROM OF drug safety concerns at Schering-Plough, Chairman and Chief Executive Officer Fred Hassan backed his turnaround plan by making the company's largest open-market transaction in years. On Thursday, Hassan purchased 110,000 shares on the open market for nearly $2.http://online.barrons.com/article/SB120907254611342857.html?mod=yahoobarrons&ru=yahooAbbott LaboratoriesFri, 25 Apr 2008 21:53:00 GMThttp://www.pharmaceutical-business-review.com/article_news.asp?guid=20C04119-D479-4110-8695-F30FB54C2F67Merck & Co. has reported that patients with dyslipidemia treated with Cordaptive reported significantly less flushing and significantly fewer discontinuations due to flushing than patients treated with Abbotts Niaspan.http://www.pharmaceutical-business-review.com/article_news.asp?guid=20C04119-D479-4110-8695-F30FB54C2F67Abbott LaboratoriesTue, 01 Apr 2008 15:59:00 GMThttp://online.wsj.com/article/SB120107788843009643.html?mod=yahoo_hs&ru=yahooAbbott Labs swung to a fourth-quarter profit amid year-earlier charges, as the company posted double-digit sales growth in its pharmaceutical business led by its blockbuster Humira.http://online.wsj.com/article/SB120107788843009643.html?mod=yahoo_hs&ru=yahooAbbott LaboratoriesWed, 23 Jan 2008 14:14:00 GMThttp://www.thestreet.com/_yahoo/newsanalysis/biotech/10398629.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAThe drug, a 50/50 venture between Biogen and Elan, is cleared to treat the rare disease.. Check out TheStreet for the latest stock market news and financial investment headlines.http://www.thestreet.com/_yahoo/newsanalysis/biotech/10398629.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAAbbott LaboratoriesMon, 14 Jan 2008 22:04:46 GMThttp://www.npsp.com/news_releasetxt.php?ReqId=180523SALT LAKE CITY, June 28 /PRNewswire/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP; Toronto: NX) and Abbott Laboratories (NYSE: ABT) announced today that preclinical and clinical data on NPS 1776 were presented at the Fifth Eilat Conference on New Antiepileptic Drugs in Eilat, Israel.http://www.npsp.com/news_releasetxt.php?ReqId=180523Abbott Laboratorieshttp://www.astrazeneca.com/article/11224.aspxAlbireo - February 2008 AstraZeneca and Nomura Phase4 Ventures announced the signing of a deal to form Albireo, a company focused on developing new treatments for gastrointestinal (GI) disorders.http://www.astrazeneca.com/article/11224.aspxAbbott Laboratorieshttp://www.kingpharm.com/kingpharm/Investors/news_details.asp?id_news=433We are extremely pleased to welcome King Pharmaceuticals as a new member company and commend its commitment to helping Americans without prescription drug coverage gain access and savings, said Roba Whiteley, executive director of Together Rx Access.http://www.kingpharm.com/kingpharm/Investors/news_details.asp?id_news=433Abbott Laboratories